Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Offices

Lab Central
700 Main Street
Cambridge, MA, 02139
USA

People

Co-Founder and VP of Licensing
Co-Founder and CEO
Co-Founder and VP of R&D
Co-Founder and VP of Policy
Chairman of Scientific Advisory Board
Board of Directors

Funding

TOTAL $3.75M
FUNDING TOTAL $3.75M
Series A, 5/2013
Norwich Ventures
Series A, 5/2013
Norwich Ventures
$3.75M

Service Providers

Legal

Tags

Vaxess Technologies

Vaxess is commercializing a proprietary technology that uses a silk-derived protein to stabilize vaccines so they can be stored and shipped without refrigeration. Vaxess strives to not only lower the cost of vaccine distribution, but also increase access to life-saving products for people around the world.

Recent Milestones

Videos

Screenshots

Vaxess Technologies screenshot
Above: Vaxess Technologies Screenshot -- #1
Uploaded: 10/22/12

Sources

  1. Aimed at Increasing Vaccine Access, Vaxess Raises the First Part of a $3.75M Series A (bostinno.streetwise.co) [edit]
  2. Aimed at Increasing Vaccine Access, Vaxess Raises the First Part of a $3.75M Series A (bostinno.streetwise.co) [edit]
  3. Harvard Business School Holds 16th Annual Business Plan Contest (hbs.edu) [edit]
    Harvard Entrepreneurs Weave Silk With Science (news.harvard.edu) [edit]
    Harvard Business School Awards More Than $300k to ‘Entrepreneurship of All Kinds’ (bostinno.streetwise.co) [edit]
    MassTLC Blog (masstlcawards.org) [edit]
Edit This Page
Last Edited 2/18/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy